Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis

Nature Genetics

Volumn 34, Issue 1, 2003, Pages 97-101

  Nicolas, Gaël ^a   Viatte, Lydie ^a   Lou, Dan Qing ^a   Bennoun, Myriam ^a   Beaumont, Carole ^b   Kahn, Axel ^a   Andrews, Nancy C ^c   Vaulont, Sophie ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; HLA ANTIGEN CLASS 1; IRON; MESSENGER RNA; PEPTIDE HORMONE; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HEMOCHROMATOSIS; HEMOSIDEROSIS; HOMOZYGOSITY; INTESTINE CELL; INTESTINE CRYPT; IRON BLOOD LEVEL; IRON OVERLOAD; MISSENSE MUTATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; RETICULOENDOTHELIAL SYSTEM; TRANSGENIC MOUSE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CROSSES, GENETIC; GENE EXPRESSION; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION, MISSENSE; PHENOTYPE; RNA, MESSENGER;

ANIMALIA; MUS MUSCULUS;

EID: 0037847496     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1150     Document Type: Article

References (24)

1. Feder, J.N. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13, 399-408 (1996).
2. Zhou, X.Y. et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. USA 95, 2492-2497 (1998).
3. Levy, J.E., Montross, L.K., Cohen, D.E., Fleming, M.D. & Andrews, N.C. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood 94, 9-11 (1999).
4. Bahram, S. et al. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc. Natl. Acad. Sci. USA 96, 13312-13317 (1999).
5. Roy, C.N. & Enns, C.A. Iron homeostasis: new tales from the crypt. Blood 96, 4020-4027 (2000).
6. Trinder, D., Olynyk, J.K., Sly, W.S. & Morgan, E.H. Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse. Proc. Natl. Acad. Sci. USA 99, 5622-5626 (2002).
7. Townsend, A. & Drakesmith, H. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Lancet 359, 786-790 (2002).
8. Drakesmith, H. et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc. Natl. Acad. Sci. USA 99, 15602-15607 (2002).
9. Finch, C. Regulators of iron balance in humans. Blood 84, 1697-1702 (1994).
10. Krause, A. et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480, 147-150 (2000).
11. Pigeon, C. et al. A new mouse liver specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811-7819 (2001).
12. Park, C.H., Valore, E.V., Waring, A.J. & Ganz, T. Hepcidin: a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276, 7806-7810 (2001).
13. Nicolas, G. et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98, 8780-8785 (2001).
14. Roetto, A. et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33, 21-22 (2003).
15. Nicolas, G. et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl. Acad. Sci. USA 99, 4596-4601 (2002).
16. Nicolas, G. et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037-1044 (2002).
17. Weinstein, D.A. et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100, 3776-3781 (2002).
18. Nemeth, E. et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101, 2461-2463 (2003).
19. Ajioka, R.S., Levy, J.E., Andrews, N.C. & Kushner, J.P. Regulation of iron absorption in Hfe mutant mice. Blood 100, 1465-1469 (2002).
20. Ahmad, K.A. et al. Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells Mol. Dis. 29, 361-366 (2002).
21. Bridle, K.R. et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669-673 (2003).
22. Courselaud, B. et al. C/EBPα regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 277, 41163-41170 (2002).
23. Yan, C., Costa, R.H., Darnell, J.E. Jr., Chen, J.D. & Van Dyke, T.A. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 9, 869-878 (1990).
24. Torrance, J.D. & Bothwell, T.H. Tissue iron stores. Methods Hematol. 1, 90-115 (1980).